不是一个破碎的心.

Same author

Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association.

Circulation·2026

Same author

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

The New England journal of medicine·2026

Same author

Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.

The oncologist·2026

Same author

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Current oncology (Toronto, Ont.)·2026

Same author

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review.

Heart failure reviews·2026

Same author

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Heart views : the official journal of the Gulf Heart Association·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

不是一个破碎的心.

相关概念视频

Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association.

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review.

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

不是一个破碎的心.

相关概念视频

相关文章

Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association.

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review.

iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.